Fast Five: Edwards reports ‘excellent’ outcomes with Sapien TAVR; SafeGuard Surgical wins FDA breakthrough nod for biodegradable stent

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.

Fast Five by MassDevice · Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent

Conformal Medical this week reported “encouraging” results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.

Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.

Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.

SafeGuard Surgical wo…

Read more
  • 0

Fast Five: Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes foundation to advance access to care

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 14, 2024.

Fast Five by MassDevice · Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation

Sooma raised $5.5 million for its depression-treating neuromodulation technology. Fast Five hosts Sean Whooley and Danielle Kirsh talk about what the company’s technology does and what it plans are for the funds.

SetPoint Medical won FDA breakthrough designation for its nerve stimulation technology for multiple sclerosis. Hear more about the technology and the executives’ optimism about the future of the technology.

Abbott is launching its latest Navitor TAVI system in the U.S. Whooley talks about the technology and Abbott’s TAVR market history.

GE Healthcare has established a foundation to advance acce…

Read more
  • 0

Fast Five: Recall of Abbott HeartMate comms system is Class I; Roman to move out of CEO post at 3M, successor named

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 13, 2024.

Fast Five by MassDevice · Recall of Abbott HeartMate comms system is Class I; Roman to move out of CEO post at 3M

GE HealthCare and Mass General are bringing artificial intelligence to imaging. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the partnership and how it can transform healthcare.

Ascensia and Senseonics have announced new CGM cost savings. Hear more about some of the cost saving initiatives and the devices that are included in the initiatives.

SS Innovations has used its surgical robot in mitral valve replacement procedures. Whooley talks about what the robot does and what people think about its performance.

3M CEO Mike Roman is stepping down as CEO and a successor has been named. Learn who is taking over the corner offic…

Read more
  • 0

Fast Five: iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 12, 2024.

Fast Five by MassDevice · iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program

Boston Scientific reported positive results for the agent drug-coated balloon study. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and the data points that stick out.

Medtronic is highlighting the global performance of its MiniMed 780G automated insulin delivery system. Hear about what the new data highlights and some of the most compelling data the company highlighted.

The FDA has cleared Pulse Biosciences’ pulsed field ablation electrode technology. Whooley talks about what the PFA electrode technology does and some of the optimism that executives have.

Onward was accepted into an FDA advisor…

Read more
  • 0

Fast Five: FTC may look at Boston Scientific’s Axonics buy, Roche unveils new AI-enabled CGM

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 8, 2024.

Fast Five by MassDevice · Fast Five: FTC may look at Boston Scientific’s Axonics buy, Roche unveils new AI-enabled CGM

Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system.

Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients.

Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company’s surgical robot and discuss the potential uses of proceeds.

Roche Diabete…

Read more
  • 0

Fast Five: Dexcom gets first OTC CGM nod from FDA, ResMed launches new mask

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 7, 2024.

Fast Five by MassDevice · Fast Five: Dexcom gets first OTC CGM nod from FDA, ResMed launches new mask

Abbott reported some positive real-world data on the use of its CGM with GLP-1s. Fast Five hosts Chris Newmarker and Sean Whooley take a look at the emergence of GLP-1s in medtech and the potential to bolster CGM technologies.

Gradient began a U.S. trial for its pulmonary denervation technology. With renal denervation garnering so much attention recently, the hosts examine another denervation technology for treating hypertension.

Orthofix posted Street-beating fourth-quarter results. With tons of changes at Orthofix over the past year, analysts seem more positive about these latest results. The Fast Five hosts look at some of the key figures from the …

Read more
  • 0

Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 6, 2024.

Fast Five by MassDevice · Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit

Medtronic may face a jury trial in a legal case over spine implants. Fast Five hosts Chris Newmarker and Sean Whooley break down the nearly decade-long history of this lawsuit and discuss the decision handed down by a judge in this case.

Baxter has decided to close a facility in Massachusetts. Listen to learn all about Baxter’s reasoning behind this facility closure and how it ties into a major acquisition made by the company a few years ago.

Dexcom announced a new direct-to-watch feature for G7 CGM. The Fast Five hosts look at what this new feature is and examine some other good news from Dexcom.

Stereotaxis submitted it…

Read more
  • 0

Fast Five: Baxter considers Kidney Care sale instead of spin, Medtronic earns FDA nod for bone ablation tech

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 5, 2024.

Fast Five by MassDevice · Fast Five: Baxter considers Kidney Care sale, Medtronic earns FDA nod for ablation tech

The FDA approved Boston Scientific’s Agent drug-coated balloon. Fast Five hosts Chris Newmarker and Sean Whooley explain the significance of this approval and dive into why analysts think it’s a major win for Boston Scientific.

BD has initiated a new trial for its Vascular Covered Stent. Find out more about what the stent does and why BD thinks it addresses a significant unmet need.

Phagenesis reportedly brought in $42 million in funding for its neurostimulation technology. The hosts take a look at what the technology actually is and what the British medtech company plans to do with its latest cash influx.

Medtronic picked up …

Read more
  • 0

Fast Five: Medtronic asks ITC to stop Axonics’ neuromod device sales; J&J’s Varipulse PFA wins CE mark approval

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 1, 2024.

Fast Five by MassDevice · Medtronic asks ITC to stop Axonics’ neuromod device sales; J&J’s Varipulse PFA wins CE mark approval

Orthofix this week appointed a new president of its Bone Growth Therapies business. Fast Five hosts Danielle Kirsh and Sean Whooley discuss who is joining the company and some of their career experience.

Affluent Medical has positive biomimetic mitral valve data. Learn more about the valve and some of the data points that study out.

Onward won an FDA breakthrough nod for use of neurostim with brain-computer interface. Whooley explains what the technology does and how this was a milestone breakthrough for the company.

J&J’s Biosense Webster’s pulsed field ablation system won CE mark approv…

Read more
  • 0

Fast Five: Integra Lifesciences CEO to retire; Philips taps Stryker exec as next CFO

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 29, 2024.

Fast Five by MassDevice · Integra Lifesciences CEO to retire; Philips taps Stryker exec as next CFO

A new report shows Insulet trumped Medtrum again in a French patent spat. Fast Five hosts Danielle Kirsh and Sean Whooley talk about what the spat was about and what the court ruled.

Stryker has reported its first shoulder arthroplasty with the Blueprint MR guidance system in Europe. Hear more about those procedures and what doctors think about the technology.

Osso VR has picked a new CEO as the former leader transitions into a new role within the company. Whooley explains who is taking over the corner office, some of their career history, and where the former CEO is transitioning into.

Philips tapped a Stryker controller as its next chief fi…

Read more
  • 0

Fast Five: A high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAA

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 28, 2024.

Fast Five by MassDevice · A high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAA

Mainstay Medical has raised $125 million for its neurostimulation technology. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the company’s plans for the funds and what the implant does.

Philips has launched its new Azurion neuro biplane system for neurovascular interventions. Learn more about what Azurion does and how it helps workflows.

Know Labs unveiled its wearable, non-invasive CGM set for FDA submission. Whooley details the technology and how it works.

J&J’s Biosense Webster has started its trial for the recently acquired Laminar left atrial appendage elimination device. Hear more …

Read more
  • 0

Fast Five: Integra Lifesciences announces a plant closure; Virtual Incision’s mini MIRA surgical robot wins FDA nod

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 27, 2024.

Fast Five by MassDevice · Integra Lifesciences closes a plant; Virtual Incision’s mini MIRA surgical robot wins FDA nod

Owlet is set to raise $9 million to support its infant monitoring technology. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the technology and some of the terms of the funding.

GE HealthCare and Biofourmis are collaborating on at-home patient monitoring. Hear more about the goal of the partnership and how it will help patients.

Irish startup Gasgon Medical is looking to raise €4 million for its IV delivery technology. Whooley explains the company’s technology and what some of the funding will support.

Virtual Incision won an FDA nod for its miniature MIRA surgical robot for use in colectomies. The …

Read more
  • 0